PET/CT in Prostate Cancer, 1st ed. 2017 PET/CT Series
Coordonnateur : Cook Gary
This pocket book explains the significant and well-documented impact that PET/CT can have on the management of prostate cancer through the provision of high-quality evidence regarding function and structure. Up-to-date information is supplied on the relevance of PET/CT to diagnosis, treatment planning, and therapy, including the emerging role of PET/CT with PSMA. Readers will also find clear explanation of the relation of the clinical and pathological background to imaging and the value of PET/CT compared with conventional radiological imaging. The book will be an excellent asset for referring clinicians, nuclear medicine/radiology physicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings. It is published within the Springer series Clinicians? Guides to Radionuclide Hybrid Imaging, which presents contributions from professionals worldwide who share a common purpose in promoting nuclear medicine as an important imaging specialty for the diagnosis and management of oncological and non-oncological conditions.
Chapter 1. Epidemiology and Clinical Features of Prostate cancer
Chapter 2. Pathology of prostate cancer
Chapter 3. Chapter 3: Management of Prostate Cancer
Chapter 4. Prostate cancer: Radiological Imaging
Chapter 5. The Role of PET/CT in Prostate Cancer Management
Chapter 6. Role of radiolabelled small molecules binding to PSMA in diagnosis and therapy of prostate cancer
Chapter 7. PET/CT in radiotherapy planning: current evidence in prostate cancer
Gary Cook is Professor of PET Imaging in the King’s College London and Guy’s & St Thomas’ PET Centre, the head of the Cancer Imaging Department in the Division of Imaging Sciences and Biomedical Engineering, King’s College London, and an honorary consultant at Guy’s & St Thomas’ Hospitals, London, UK. He is a member of the Guy’s and St Thomas’ Hospitals prostate cancer multidisciplinary team, imaging lead for the King’s Health Partners Prostate Cancer Research group, and a member of the UK National Cancer Research Institute Prostate Cancer Clinical Studies Group.
Clarifies the impact of PET/CT on different aspects of the management of prostate cancer
Explains the relevance of the clinical and pathological background to imaging
Examines the value of PET/CT in relation to conventional radiological imaging
Date de parution : 08-2017
Ouvrage de 60 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 68,56 €
Ajouter au panierThème de PET/CT in Prostate Cancer :
Mots-clés :
PET/CT; Hybrid Imaging; Prostate Cancer; MRI; Radiotherapy; Prostate Specific Membrane Antigen